Carpal Tunnel Syndrome

• Mechanical compression and increased carpal tunnel pressure: The carpal tunnel is a fixed anatomical space bounded by carpal bones dorsally and the flexor retinaculum (transverse carpal ligament) palmarly. Normally, carpal tunnel pressure measures 2-10 mmHg at rest; in CTS, pressures frequently exceed 30-40 mmHg, rising further with wrist flexion or extension. Any process increasing tunnel volume (synovial thickening, tenosynovitis, space-occupying lesions) or decreasing tunnel capacity (flexor retinaculum hypertrophy, carpal bone malalignment) generates pressure elevation. Repetitive hand use, particularly with prolonged wrist flexion/extension, increases intratunnel pressure as tendon friction generates inflammatory mediator release (prostaglandins, cytokines) within the confined space. The median nerve, which occupies approximately 50% of tunnel cross-sectional area, becomes compressed against the relatively unyielding bony carpal arch.

• Median nerve microvascular dysfunction and ischemia: Elevated carpal tunnel pressure directly compresses the intraneural microvasculature supplying the median nerve. Normal nerve blood flow is maintained by capillary pressure exceeding tissue pressure; when tissue pressure exceeds 30 mmHg, capillary perfusion fails. Chronic intermittent ischemia activates hypoxia-inducible transcription factors (HIF-1α) within nerve cells, triggering upregulation of vascular endothelial growth factor (VEGF) and other angiogenic factors. However, paradoxically, the initially beneficial angiogenic response becomes maladaptive: newly formed vessels are immature with increased permeability, leading to increased interstitial edema and further pressure elevation—a positive feedback loop. Additionally, ischemic conditions impair the nerve's ability to synthesize protective factors; myelin-producing Schwann cells become metabolically compromised, and axonal transport slows dramatically (from 100-400 mm/day in normal nerves to 2-5 mm/day in compressed nerves). This impaired axonal transport reduces delivery of critical structural proteins, growth factors, and mitochondria distally, causing distal axonal degeneration preferentially affecting sensory fibers initially (which explains why sensory symptoms typically precede motor involvement).

• Inflammatory cascade and glial response: Chronic median nerve compression triggers activation of resident glial cells and recruitment of peripheral immune cells. Endoneurial macrophages and Schwann cells produce elevated levels of pro-inflammatory cytokines including tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and interleukin-8 (IL-8). These cytokines upregulate cyclooxygenase-2 (COX-2) activity, increasing local prostaglandin E2 (PGE2) production, which contributes to pain generation and increases vascular permeability. TNF-α signaling through TNFR1 receptors on axons sensitizes nociceptors and may directly promote demyelination by reducing myelin stability. The inflammatory milieu also activates matrix metalloproteinases (MMPs, particularly MMP-2 and MMP-9), which degrade the perineurium and endoneurial extracellular matrix, further disrupting the blood-nerve barrier and exacerbating edema and inflammatory cell infiltration.

• Progressive demyelination and axonal degeneration: In mild CTS, compression predominantly causes segmental demyelination—loss of myelin wrapping with preserved axonal continuity—primarily at the proximal and distal compression sites where mechanical stress is greatest. Electrophysiologically, this manifests as slowed conduction velocity and conduction block. Chronically elevated pressure impairs the myelinating Schwann cell's metabolic function; these cells cannot maintain myelin integrity under sustained ischemic stress and begin to withdraw myelin lamellae from affected axons. With disease progression and continued ischemia, secondary axonal degeneration occurs—the axon itself degenerates, beginning distally in smaller-diameter fibers (pain and temperature fibers) and progressing proximally as severity increases. Advanced CTS shows evidence of axonal loss on needle electromyography. Importantly, if axonal degeneration occurs, recovery becomes incomplete even after successful nerve decompression, as axonal regeneration requires weeks to months and may be incomplete.

• Thenar muscle denervation and atrophy: In severe CTS with motor involvement, chronic denervation of thenar muscles (predominantly abductor pollicis brevis innervated by the recurrent motor branch of the median nerve, which emerges distally within the carpal tunnel and is particularly vulnerable to compression) leads to progressive muscle fiber atrophy. Motor denervation occurs later than sensory because motor axons are larger and more resistant to ischemia (larger diameter allows better oxygen diffusion from interstitial space; can tolerate slightly lower pressures). As motor fibers denervate, remaining functional motor units increase in size to maintain strength—a process called motor unit remodeling. Eventually, if denervation persists, permanent muscle atrophy and weakness develop, manifesting clinically as impaired thumb opposition and pinch weakness.

• Idiopathic/primary CTS (most common; 90% of cases): In the majority of CTS cases, no specific causative factor is identified. These likely result from cumulative effects of occupational/recreational hand use, individual variations in carpal tunnel anatomy, and possibly genetic predisposition to developing tenosynovitis or structural changes. Women are affected 2-3 times more frequently than men, suggesting hormonal influences (estrogen, progesterone) may increase susceptibility to inflammation or fluid retention within the carpal tunnel. Peak incidence occurs between 40-60 years of age. Occupational factors involving repetitive wrist flexion/extension (assembly line workers, office workers with prolonged computer use, musicians, carpenters) or forceful gripping increase risk, though the epidemiologic evidence is mixed and workplace ergonomics modifications show modest benefit only.

• Metabolic and endocrine disorders: Hypothyroidism ranks among the most common secondary causes of CTS, occurring in 10-20% of hypothyroid patients; myxedema creates increased interstitial fluid and glycosaminoglycan deposition, expanding carpal tunnel contents and compressing the nerve. Diabetes mellitus increases CTS risk 2-5 fold; hyperglycemia promotes glycation of proteins in connective tissues and increases inflammatory mediator production, causing flexor tenosynovitis and reducing nerve's ability to tolerate compression. Acromegaly causes CTS through overgrowth of bone and soft tissues, narrowing the carpal tunnel; CTS develops in 25-40% of acromegaly patients and may be the presenting sign. Amyloidosis (particularly in dialysis-related amyloidosis from long-term renal failure or AL amyloidosis) deposits amyloid fibrils within the carpal tunnel, creating a mass effect and ischemia.

• Inflammatory and rheumatologic conditions: Rheumatoid arthritis causes CTS through inflammatory synovitis of the nine flexor tendons crowded within the carpal tunnel; the inflamed synovium thickens and expands, compressing the median nerve. CTS occurs in 20-40% of RA patients. Systemic lupus erythematosus, seronegative spondyloarthropathies, and other inflammatory arthropathies similarly cause median nerve compression through tenosynovitis.

• Pregnancy and hormonal factors: CTS is the most common entrapment neuropathy in pregnancy, occurring in 5-15% of pregnant women, particularly in the third trimester when fluid retention peaks. Hormonal influences (progesterone increases water retention; estrogen increases inflammatory mediators) combined with pregnancy-related weight gain increase carpal tunnel contents. Symptoms typically resolve within 3 months postpartum, though some women experience persistent CTS. Postmenopausal women using hormone replacement therapy show modestly increased CTS risk.

• Occupational trauma and repetitive strain: Acute wrist trauma (fractures, dislocations) can cause CTS through direct nerve injury, edema, hemorrhage within the tunnel, or subsequent scar formation and flexor tenosynovitis. Chronic repetitive wrist motion (vibration exposure, prolonged typing, assembly line work) may contribute to tenosynovitis and pressure elevation, though individual susceptibility varies widely. The evidence for strict causation is controversial, but occupational factors likely contribute in genetically susceptible individuals.

• Structural and anatomical factors: Carpal tunnel anatomy varies significantly; individuals with smaller tunnel diameters (particularly in women and those of certain ethnic backgrounds) are at higher baseline risk. Carpal bone malalignment (previous carpal fractures, severe osteoarthritis of carpal joints) reduces tunnel capacity. Anomalous muscles (such as an accessory abductor pollicis longus or palmaris profundus) can occupy tunnel space.

• Systemic conditions and masses: Hypothyroidism (already discussed as metabolic cause), obesity (increasing body weight increases fluid retention and intra-abdominal pressure), renal failure (uremia promotes inflammation and amyloid accumulation), and liver disease with ascites (increases fluid retention globally). Space-occupying lesions within the carpal tunnel are rare but important to exclude; these include ganglion cysts (arising from wrist joints, extending into tunnel), lipomas, tenosynovial giant cell tumors, and even malignancy.

• Paresthesias (classic presenting symptom): Patients typically experience tingling and numbness in the median nerve distribution—the thumb, index finger, middle finger, and radial (lateral) half of the ring finger. Critically, these symptoms characteristically spare the little finger and ulnar half of ring finger (ulnar nerve distribution), and spare the dorsal hand and dorsal fingers (these are supplied by superficial radial nerve, which exits the carpal tunnel before the wrist). Paresthesias often wake patients at night (nocturnal paresthesias occur in >50% of CTS patients), as patients sleep with wrists flexed, further increasing carpal tunnel pressure; patients report awakening needing to shake their hand, "flick" the wrist, or hold it in a neutral position to relieve symptoms. Daytime paresthesias are triggered by activities requiring sustained wrist flexion (driving, holding a phone, reading, typing) and improve with wrist extension and rest. Symptoms are often described as "pins and needles," tingling, or sometimes a burning quality in early stages.

• Pain and discomfort: Unlike pure sensory neuropathies, CTS frequently causes pain rather than pure numbness. Pain is typically localized to the wrist, palm, and fingers in the median distribution but may radiate proximally up the forearm (sometimes to the elbow or even upper arm), which can create diagnostic confusion with cervical radiculopathy. The pain is typically dull and aching rather than sharp (though some patients experience burning pain). Night pain is common and often more troublesome than daytime symptoms; patients may be unable to sleep comfortably and develop secondary sleep disturbance. Daytime pain worsens with repetitive hand use and improves with rest and wrist immobilization.

• Hand weakness and functional impairment: As CTS becomes more severe, patients note progressive weakness affecting fine motor tasks. Grip strength declines (objectively measurable with dynamometry), but more specifically, patients report difficulty with thumb opposition and pinch strength, manifesting as trouble with tasks like buttoning buttons, grasping pens, opening jars, or performing fine manipulations. This weakness reflects denervation of the recurrent motor branch of the median nerve supplying the abductor pollicis brevis (APB) and flexor pollicis brevis (FPB) muscles. Some patients report dropping objects or experiencing clumsiness. Importantly, motor symptoms indicate more advanced disease and predict worse long-term outcomes.

• Physical examination findings: Tinel sign: Percussion over the median nerve at the wrist (just proximal to the wrist crease, over the nerve's course between palmaris longus and flexor carpi radialis tendons) produces a sudden electric tingling sensation radiating distally into the median nerve distribution. This Tinel sign reflects mechanically irritated regenerating axons and hyperexcitable nerve membrane. Sensitivity is 50-60%; specificity is 70%. A positive Tinel sign indicates active nerve pathology (either compression or regeneration) but is not specific for CTS and occurs in other median nerve lesions. The sign is more often positive in mild-to-moderate disease; in severe disease with significant axonal loss, regenerating axons may be sparse and Tinel sign may be absent.

• Physical examination findings: Phalen maneuver (wrist flexion test): The examiner has the patient maximally flex both wrists (bringing dorsal hand surfaces together) and hold this position for 60 seconds. Reproduction of paresthesias or pain in the median nerve distribution constitutes a positive test. This maneuver further increases carpal tunnel pressure through mechanical compression and ischemia, reproducing symptoms. Sensitivity is 50-80%; specificity is 90%, making it highly specific when positive. A negative Phalen maneuver argues against CTS. This test can be made more sensitive by having patient actively flex wrists maximally rather than passively flexing.

• Physical examination findings: Carpal compression test: The examiner applies direct moderate pressure over the carpal tunnel (over the flexor retinaculum at the wrist) for 30 seconds. Reproduction of paresthesias constitutes a positive test. This directly increases carpal tunnel pressure mechanically. Sensitivity 60-70%; specificity 98%, making it highly specific. Some sources suggest this test may be more sensitive than Phalen maneuver.

• Motor findings in advanced CTS: Atrophy of thenar eminence (particularly abductor pollicis brevis, visible as flattening or hollowing of the thenar mound on the radial palm) indicates chronic denervation and severe disease. Thumb opposition weakness (inability to abduct thumb against resistance or loss of thumb opposition) reflects denervation of APB. The Semmes-Weinstein monofilament test may show diminished sensation to light touch in median distribution. Two-point discrimination may be elevated (>6 mm in median distribution), though this is less sensitive than other tests. Hand grip strength is reduced, though this is non-specific as it reflects general hand function.

• Important clinical variants and red flags:
• Bilateral CTS: Occurring in 50-60% of patients with unilateral symptoms. Bilateral presentation should raise suspicion for metabolic/systemic causes (hypothyroidism, diabetes, amyloidosis) or suggests that predisposing factors affect both hands equally.
• Atypical pain patterns: While classic CTS causes median distribution symptoms, pain sometimes extends beyond median distribution or shows atypical radiation; this can create confusion with cervical radiculopathy. Cervical C6 radiculopathy causes thumb/index finger pain but also involves the dorsal hand (not typical of CTS) and typically worsens with neck extension/lateral flexion.
• Severe acute CTS: Acute severe compression (from hemorrhage within tunnel after trauma, acute tenosynovitis) can present with rapid onset of weakness and sensory loss and represents a surgical emergency.
• Painless CTS: Some patients, particularly with longstanding disease and axonal loss, experience only numbness and weakness without pain; this may be overlooked until significant functional impairment develops.

• Clinical diagnosis and history taking: History remains the most sensitive tool for CTS diagnosis. Key historical features supporting CTS include: (1) nocturnal paresthesias (waking at night with hand numbness/tingling, needing to shake hand or change position to relieve symptoms)—this is highly suggestive; (2) median nerve distribution symptoms (thumb, index, middle, and radial ring finger); (3) occupational or activity-related exacerbation with repetitive wrist use; (4) **improvement with wrist rest or immobilization

Immediate/urgent decisions

• Acute carpal tunnel syndrome: rapidly progressive sensory loss or thenar weakness after distal radius fracture, perilunate dislocation, or bleeding into the tunnel (anticoagulation, hemophilia) is a surgical emergency — the mechanism is a closed-compartment rise in pressure causing nerve ischemia. Emergent decompression, not splinting, is the answer.
• Treat the driver: levothyroxine for hypothyroidism, glycemic control in diabetes, medical/surgical therapy for acromegaly, and evaluation for amyloidosis in dialysis or bilateral spontaneous cases. Pregnancy-related CTS is managed conservatively because symptoms usually remit postpartum.

First-line (mild–moderate, no axonal loss)

• Neutral-position wrist splint: worn nightly (full-time if tolerated). The wrist is held in ~neutral because both flexion and extension raise intratunnel pressure. The American Academy of Orthopaedic Surgeons (AAOS) clinical practice guideline on management of CTS supports immobilization as an effective non-operative option.
• Activity/ergonomic modification: reduces repetitive loading; AAOS notes only modest benefit, so it is an adjunct rather than definitive therapy.
• NSAIDs (e.g., ibuprofen): reasonable for pain, but evidence for altering the natural history is weak; they do not decompress the nerve.

Escalation / second line

• Local corticosteroid injection (e.g., methylprednisolone) into the carpal tunnel: supported by AAOS; reduces synovial edema and gives short- to intermediate-term relief. Injection is placed ulnar to the palmaris longus to avoid intraneural injection. A robust response also predicts good surgical outcome.
• Short-course oral corticosteroids: an alternative when injection is declined or unavailable.

Definitive management

• Carpal tunnel release (open or endoscopic): division of the transverse carpal ligament. Indicated for failure of non-operative therapy, electrodiagnostically severe disease, or any thenar atrophy/motor deficit. AAOS supports surgical release over continued non-operative care for these patients; endoscopic and open techniques have comparable long-term outcomes.

Low-value or avoid

• Oral diuretics and pyridoxine (vitamin B6): AAOS does not support these; B6 in excess itself causes a sensory neuropathy.
• Repeated steroid injections: risk flexor tendon rupture and nerve injury.
• Do not splint-and-wait when thenar atrophy is already present — delay converts a recoverable demyelinating lesion into permanent axonal loss.

Complications of untreated disease

• Permanent thenar atrophy and opposition weakness: sustained ischemia converts segmental demyelination into axonal degeneration of the recurrent motor branch. Signaled by visible hollowing of the thenar eminence, weak thumb abduction against resistance, and fibrillations/reduced recruitment on needle EMG. Because regeneration is slow and incomplete, this is the point after which decompression may not restore function.
• Loss of protective sensation: chronic sensory axon loss produces dense numbness with elevated two-point discrimination; patients sustain unnoticed burns and cuts of the fingertips.
• "Ape hand" appearance: with severe thenar wasting the thumb rests adducted in the plane of the palm — a late, chronic finding, not an acute one.
• Acute carpal tunnel syndrome (emergency): hematoma or post-traumatic swelling raising tunnel pressure produces rapidly worsening pain, numbness, and weakness; requires urgent release to prevent infarction of the nerve.

Complications of treatment

• Corticosteroid injection: intraneural injection causing worsened paresthesias, flexor tendon rupture with repeated injections, local fat atrophy and skin hypopigmentation, and transient hyperglycemia in diabetics.
• Incomplete release: the most common cause of persistent postoperative symptoms — the distal transverse carpal ligament is left partly intact, so symptoms and electrodiagnostic abnormalities persist unchanged.
• Injury to the recurrent motor branch: iatrogenic thenar palsy with new inability to oppose the thumb.
• Injury to the palmar cutaneous branch: numbness or a painful neuroma over the thenar eminence — a nerve territory that is spared in CTS itself, so new thenar-skin numbness after surgery implicates the operation.
• Injury to the superficial palmar arch: brisk intraoperative or postoperative bleeding; an expanding postoperative hematoma re-compressing the nerve is an emergency.
• Pillar pain and scar tenderness: aching at the thenar/hypothenar bases for weeks to months; usually self-limited.
• Surgical site infection or flexor tenosynovitis (emergency): fever, spreading erythema, and pain on passive finger extension mandate urgent evaluation.
• Complex regional pain syndrome: disproportionate burning pain with vasomotor and trophic skin changes after an otherwise technically successful release.

• The buzzword cluster: nocturnal paresthesias in the thumb, index, middle, and radial half of the ring finger relieved by shaking the hand (flick sign), with a positive Tinel sign and Phalen maneuver. Highly specific provocative tests, poorly sensitive ones — a negative exam does not exclude CTS.
• The anatomy question examiners love: the palmar cutaneous branch of the median nerve arises proximal to the flexor retinaculum and travels superficial to it, so sensation over the thenar eminence is preserved in CTS. Thenar skin numbness points to a more proximal median lesion (pronator teres syndrome, forearm trauma) — or to iatrogenic injury after release.
• Single best next step, mild disease: a neutral wrist splint worn at night, not immediate surgery and not imaging. Escalate to carpal tunnel corticosteroid injection if splinting fails.
• Single best next step, thenar atrophy or motor weakness: surgical carpal tunnel release — continued conservative therapy is the wrong answer once axonal loss is present.
• The association to know: bilateral, spontaneous CTS should prompt a search for a systemic cause — hypothyroidism, diabetes, acromegaly, rheumatoid tenosynovitis, pregnancy, and amyloidosis. Bilateral CTS can precede clinical transthyretin cardiac amyloidosis by years, and dialysis patients accumulate β2-microglobulin amyloid in the tunnel.
• The classic distractor: C6/C7 cervical radiculopathy. Radiculopathy involves the dorsal hand and forearm, follows a dermatome beyond the wrist, worsens with neck extension/rotation (Spurling maneuver), and may reduce the brachioradialis or triceps reflex. CTS never causes reflex loss and never involves the dorsal hand (superficial radial nerve).
• The second distractor: ulnar neuropathy. Little-finger and ulnar ring-finger involvement, interosseous wasting, and Froment sign are ulnar findings — CTS spares these.
• Earliest electrodiagnostic abnormality: prolonged distal median sensory latency, reflecting focal demyelination before axonal loss; needle EMG denervation is a late, severity-defining finding.
• Do not pick vitamin B6 or a diuretic — neither is supported by the AAOS guideline, and excess pyridoxine itself causes a sensory neuropathy.